These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31099405)

  • 1. Genome-wide gene expression in a pharmacological hormonal transition model and its relation to depressive symptoms.
    Mehta D; Rex-Haffner M; Søndergaard HB; Pinborg A; Binder EB; Frokjaer VG
    Acta Psychiatr Scand; 2019 Jul; 140(1):77-84. PubMed ID: 31099405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study.
    Mehta D; Rex-Haffner M; Søndergaard HB; Pinborg A; Binder EB; Frokjaer VG
    Br J Psychiatry; 2019 Sep; 215(3):519-527. PubMed ID: 30457060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological sex hormone manipulation as a risk model for depression.
    Frokjaer VG
    J Neurosci Res; 2020 Jul; 98(7):1283-1292. PubMed ID: 32399989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal volume changes in a pharmacological sex-hormone manipulation risk model for depression in women.
    Borgsted C; Hoegsted E; Henningsson S; Pinborg A; Ganz M; Frokjaer VG
    Horm Behav; 2022 Sep; 145():105234. PubMed ID: 35905507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study.
    Frokjaer VG; Pinborg A; Holst KK; Overgaard A; Henningsson S; Heede M; Larsen EC; Jensen PS; Agn M; Nielsen AP; Stenbæk DS; da Cunha-Bang S; Lehel S; Siebner HR; Mikkelsen JD; Svarer C; Knudsen GM
    Biol Psychiatry; 2015 Oct; 78(8):534-43. PubMed ID: 26004162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of emotional processing in depressive responses to sex-hormone manipulation: a pharmacological fMRI study.
    Henningsson S; Madsen KH; Pinborg A; Heede M; Knudsen GM; Siebner HR; Frokjaer VG
    Transl Psychiatry; 2015 Dec; 5(12):e688. PubMed ID: 26624927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormone manipulation slows reaction time and increases labile mood in healthy women.
    Stenbæk DS; Fisher PM; Budtz-Jørgensen E; Pinborg A; Hjordt LV; Jensen PS; Knudsen GM; Frokjaer VG
    Psychoneuroendocrinology; 2016 Jun; 68():39-46. PubMed ID: 26943343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial.
    Fisher PM; Larsen CB; Beliveau V; Henningsson S; Pinborg A; Holst KK; Jensen PS; Svarer C; Siebner HR; Knudsen GM; Frokjaer VG
    Neuropsychopharmacology; 2017 Jan; 42(2):446-453. PubMed ID: 27649641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-pubertal gonadotropin-releasing hormone agonist treatment affects sex biased gene expression of amygdala in sheep.
    Nuruddin S; Krogenæs A; Brynildsrud OB; Verhaegen S; Evans NP; Robinson JE; Haraldsen IR; Ropstad E
    Psychoneuroendocrinology; 2013 Dec; 38(12):3115-27. PubMed ID: 24103890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Steroid Hormone Manipulation Reduces Brain Response to Reward.
    Macoveanu J; Henningsson S; Pinborg A; Jensen P; Knudsen GM; Frokjaer VG; Siebner HR
    Neuropsychopharmacology; 2016 Mar; 41(4):1057-65. PubMed ID: 26245498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women.
    Stenbæk DS; Budtz-Jørgensen E; Pinborg A; Jensen PS; Frokjaer VG
    Psychoneuroendocrinology; 2019 Jan; 99():251-256. PubMed ID: 30390443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women.
    Joffe H; Crawford SL; Freeman MP; White DP; Bianchi MT; Kim S; Economou N; Camuso J; Hall JE; Cohen LS
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3847-3855. PubMed ID: 27680875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment.
    Rahmawati E; Yang WV; Lei YP; Maurya PK; Chen HW; Tzeng CR
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin hormone releasing hormone agonists alter prefrontal function during verbal encoding in young women.
    Craig MC; Fletcher PC; Daly EM; Rymer J; Cutter WJ; Brammer M; Giampietro V; Wickham H; Maki PM; Murphy DG
    Psychoneuroendocrinology; 2007; 32(8-10):1116-27. PubMed ID: 17980497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotrophin-releasing hormone antagonists for assisted conception.
    Al-Inany H; Aboulghar M
    Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
    Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
    Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL.
    Deng L; Li XL; Ye DS; Blockeel C; Zhou XY; Chen SL; Chen X
    Curr Med Sci; 2019 Apr; 39(2):278-284. PubMed ID: 31016522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Siristatidis CS; Gibreel A; Basios G; Maheshwari A; Bhattacharya S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD006919. PubMed ID: 26558801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache.
    Martin V; Wernke S; Mandell K; Zoma W; Bean J; Pinney S; Liu J; Ramadan N; Rebar R
    Headache; 2003 Apr; 43(4):309-21. PubMed ID: 12656701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in vitro fertilization.
    Kaye L; Griffin D; Thorne J; Neuber E; Nulsen J; Benadiva C; Engmann L
    Fertil Steril; 2019 Sep; 112(3):534-544. PubMed ID: 31227286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.